+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Are β-Adrenergic Mechanisms Involved in Ocular Hypotensive Actions of Adrenergic Drugs?

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Specific β<sub>1</sub>- and β<sub>2</sub>-adrenergic agonists and antagonists were studied for their effects on aqueous humor dynamics in a cat model. Tazolol (β<sub>1</sub>-agonist) reduced formation of aqueous humor more than outflow, while metoprolol (β<sub>1</sub>-antagonist) reduced outflow more than formation. Both salbutamol (β<sub>2</sub>-agonist) and butoxamine (β<sub>2</sub>-antagonist) inhibited aqueous humor formation and aqueous humor outflow to an equal extent. It is concluded that the adrenergic mechanism is functioning only slightly, if at all, in affecting the intraocular pressure. On the other hand, receptor binding experiments on iris-ciliary body showed clearly that there are 40-fold and 281-fold differences in binding affinity of D- and L-isomers of timolol and propranolol, respectively. These results indicate that the adrenergic receptor mechanism does exist in the eye tissues but that it does not control intraocular pressure significantly.

          Related collections

          Author and article information

          Ophthalmic Res
          Ophthalmic Research
          S. Karger AG
          04 December 2009
          : 17
          : 1
          : 49-53
          Department of Medical Pharmacology and Toxicology, Texas A&amp;M University College of Medicine, College Station, Tex., USA
          265349 Ophthalmic Res 1985;17:49–53
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Original Paper


          Comment on this article